✦ LIBER ✦

Different variations of a passive safety containment for a BWR with active and passive safety systems

✍ Scribed by Takashi Sato; Hirohide Oikawa; Makoto Akinaga; Tsunekazu Murakami

Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 585 KB
Volume: 235
Category: Article
ISSN: 0029-5493
DOI: 10.1016/j.nucengdes.2005.03.008

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Methodology for the reliability evaluati

Methodology for the reliability evaluation of a passive system and its integration into a Probabilistic Safety Assessment

✍ Michel Marquès; J.F. Pignatel; P. Saignes; F. D’Auria; L. Burgazzi; C. Müller; R 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 459 KB

System design for isolation of a neonata

System design for isolation of a neonatal transport unit using passive and semi-active control strategies

✍ Michael Bailey-Van Kuren; Amit Shukla 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 376 KB

Delay-dependent robust passive control f

Delay-dependent robust passive control for a class of nonlinear systems with time-varying delays

✍ Jiqing Qiu; Zhifeng Gao; Yuanqing Xia; Jinhui Zhang 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 153 KB

## Abstract In this paper, the problem of robust passive control for a class of nonlinear systems with time‐varying delays is considered. The uncertainties investigated in this paper are norm bounded and time varying, and they enter all system matrices. Based on the Lyapunov–Krasovskii functionals

A phase II, multicenter, open-label stud

A phase II, multicenter, open-label study evaluating dosing and preliminary safety and efficacy of canakinumab in systemic juvenile idiopathic arthritis with active systemic features

✍ Nicolino Ruperto; Pierre Quartier; Nico Wulffraat; Patricia Woo; Angelo Ravelli; 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 311 KB 👁 2 views

A nonreplicating adenoviral vector that

A nonreplicating adenoviral vector that contains the wild-type p53 transgene combined with chemotherapy for primary breast cancer : Safety, efficacy, and biologic activity of a novel gene-therapy approach

✍ Massimo Cristofanilli; Savitri Krishnamurthy; Laura Guerra; Kristine Broglio; Ba 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 345 KB 👁 1 views

Safety and tolerability of a modified fi

Safety and tolerability of a modified filter-type device for leukocytapheresis using ACD-A as anticoagulant in patients with mild to moderately active ulcerative colitis. Results of a pilot study

✍ Vladislaw Muratov; Joachim Lundahl; Aleksandra Mandic-Havelka; Kerstin Elvin; Åk 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB

## Abstract Cellsorba™ is a medical device for leukocytapheresis (LCAP) treatment of ulcerative colitis (UC). Cellsorba™ EX Global type has been developed from Cellsorba E for intended use with ACD‐A as anticoagulant. We evaluated safety and efficacy of the modified Cellsorba using ACD‐A in a pilot